Details for: BLINCYTO
Company: AMGEN CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02450283 | BLINCYTO | BLINATUMOMAB | 38.5 MCG / VIAL | POWDER FOR SOLUTION | INTRAVENOUS |
Summary Reports
Summary Basis of Decision
Summary Basis of Decision
Regulatory Decision Summary
Regulatory Decision Summary
Regulatory Decision Summary
Summary Basis of Decision
Regulatory Decision Summary
Regulatory Decision Summary
Regulatory Decision Summary
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.